AlphaCrest Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,786
Closed -$6.16M 236
2022
Q3
$6.16M Buy
34,786
+16,450
+90% +$3.25M 0.38% 9
2022
Q2
$3.75M Buy
18,336
+11,620
+173% +$2.46M 0.18% 117
2022
Q1
$1.6M Buy
6,716
+1,968
+41% +$462K 0.09% 330
2021
Q4
$1.08M Sell
4,748
-1,724
-27% -$379K 0.04% 749
2021
Q3
$1.25M Sell
6,472
-17,641
-73% -$3.57M 0.06% 512
2021
Q2
$5.13M Sell
24,113
-6,825
-22% -$1.44M 0.22% 103
2021
Q1
$6.32M Buy
30,938
+6,473
+26% +$1.27M 0.35% 44
2020
Q4
$4.45M Buy
24,465
+11,038
+82% +$1.88M 0.37% 41
2020
Q3
$2.25M Sell
13,427
-14,163
-51% -$2.39M 0.24% 73
2020
Q2
$4.48M Buy
27,590
+22,557
+448% +$4.04M 0.75% 7
2020
Q1
$870K Sell
5,033
-21,782
-81% -$4.34M 0.11% 326
2019
Q4
$5.38M Buy
26,815
+17,330
+183% +$3.56M 0.44% 19
2019
Q3
$2M Sell
9,485
-6,207
-40% -$1.3M 0.12% 234
2019
Q2
$3.05M Sell
15,692
-38,085
-71% -$7.02M 0.26% 67
2019
Q1
$8.85M Buy
+53,777
New +$9.51M 1.34% 1

Other funds holding CME

AlphaCrest Capital Management's CME Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of CME Group (CME) in Q4 2022, closing a stake of 34,786 shares — an estimated $6.16M sold.

AlphaCrest Capital Management first reported a position in CME in Q1 2019 and held it in 15 quarters. The position peaked at $8.85M in Q1 2019. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 34,786 CME Group shares in Q4 2022, an estimated $6.16M.
  • AlphaCrest Capital Management first reported a position in CME Group in Q1 2019 and held it in 15 quarters.
  • AlphaCrest Capital Management's CME Group position peaked at $8.85M in Q1 2019.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.